Evidence map›Paper›PMID 37881687›Full record

ReviewFrontiers in pain research (Lausanne, Switzerland)2023

Medication-overuse headache-a review of different treatment strategies.

Abouch Krymchantowski, Carla Jevoux, Ana Gabriela Krymchantowski, Luiza Barbosa Ramos, Jackeline S S Barbosa, Raimundo Pereira Silva-Neto

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pain research (Lausanne, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Somatic amplification and addiction profile as risk factors for medication overuse headache with chronic migraine.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution.

Abouch KrymchantowskiHeadache Center of Rio, Rio de Janeiro, Brazil.
Carla JevouxHeadache Center of Rio, Rio de Janeiro, Brazil.
Ana Gabriela KrymchantowskiHeadache Center of Rio, Rio de Janeiro, Brazil.
Luiza Barbosa RamosHeadache Center of Rio, Rio de Janeiro, Brazil.
Jackeline S S BarbosaHeadache Center of Rio, Rio de Janeiro, Brazil.
Raimundo Pereira Silva-NetoFederal University of the Parnaíba Delta, Parnaíba, Brazil.
Universidade Federal do Delta do Parnaíba

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medication-overuse headache (MOH) can develop from primary headaches. MOH is usually the result of overuse of symptomatic medications. It is a noteworthy personal and societal burden. The identification and treatment of patients at risk for MOH is an essential component of MOH management. Medication overuse can be modifiable and can advance from episodic to chronic migraine. Treatment for MOH is complex, and experts in the field have varied views on the most appropriate strategy for MOH treatment. The objective of this review is to give a comprehensive synopsis of the literature for the management of MOH. Treatment strategies, such as detoxification and prevention, are the debatable issues. Medication withdrawal is the foundation for management. The available literature suggested abrupt withdrawal with preventive approaches for early management. Bridging therapy could be useful to get relief from withdrawal symptoms. Multidisciplinary choices proved beneficial in supporting withdrawal and preventing relapse. Worldwide, the termination of overused medications has been observed as a standard treatment strategy; however, patient-specific approaches should be taken.

Indexed as

chronic migrainemedication-overuse headachepreventive medicationssecondary headachetreatmentwithdrawal

Identifiers

PMID37881687
PMCPMC10597723
OpenAlexW4387500953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.